Skip to content
healthcare.dev

lisdexamfetamine dimesylate

NDC 0480-9739, lisdexamfetamine dimesylate, tablet, chewable, from Teva Pharmaceuticals, Inc..

Product NDC
0480-9739
Status
Listed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215415
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-9739 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE30 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
0480-9739-0100480973901100 TABLET, CHEWABLE in 1 BOTTLE (0480-9739-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bdb03bfa-0398-41e5-8e73-ded696cbca32
  • NADAC price for package 00480973901

    GET /v1/drugs/nadac/00480973901

Use it

Look up 0480-9739 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-9739 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-9739. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.